Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An update from Konica Minolta ( (JP:4902) ) is now available.
Konica Minolta has completed the transfer of its shares in Ambry Genetics Corporation to Tempus AI, Inc., effectively removing Ambry Genetics from its consolidated subsidiaries. This strategic move is expected to impact Konica Minolta’s financial results for the fiscal year ending March 31, 2025, with further announcements to be made as necessary.
More about Konica Minolta
Konica Minolta, Inc. operates in the technology industry, focusing primarily on imaging products and services, including office equipment, production print solutions, and industrial optical systems. The company is listed on the Tokyo Prime Market and is recognized for its innovative solutions in digital transformation and healthcare diagnostics.
YTD Price Performance: -2.28%
Average Trading Volume: 2,278
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2B
For an in-depth examination of 4902 stock, go to TipRanks’ Stock Analysis page.
